Awardee OrganizationMASSACHUSETTS INSTITUTE OF TECHNOLOGY
Description
Abstract Text
Project Summary/Abstract:
The ability to systematically construct highly functionalized molecules in a general and reliable manner
is central to synthetic organic chemistry and key for drug discovery, development, and scale-up in both
academia and, in particular, the pharmaceutical industry. Our proposed work includes palladium-
catalyzed cross coupling methods for the formation of aromatic and heterocyclic carbon-nitrogen bonds,
carbon-oxygen bonds and carbon-fluorine bonds. One aspect of the chemistry that we are proposing
involves the design of improved ligands and methods for aromatic carbon-heteroatom bond formation.
Our work in this area is used throughout academia and industry for the preparation of complex molecules
and has become mainstay processes for synthetic chemists. As part of this, we have developed
numerous new ligands and catalysts that are now commercially available and widely employed. The
invention of new, more general, and more user-friendly techniques will not only allow access to important
compounds but also the means to be able to efficiently and selectively modify them. This allows chemists
to rationally make new derivatives, with decreased side effects and better properties. We are also working
on copper-catalyzed methods for the highly regio-, diastereo-, and enantioselective synthesis of aliphatic
amines, copper-catalyzed methods for the asymmetric formation of carbon-carbon bonds and dual
copper- and palladium-catalyzed processes. A portion of this work aims to design new more
economically, environmentally, and generally applicable methods for the formation of carbon-carbon
bonds by using alkenes as pronucleophiles. We wish to develop chemistry that will allow us to replace
standard, highly reactive reactants with more benign and useful ones. We will also carry out mechanistic
studies to help understand the fundamental features of these transformations and to help guide us in
advancing the efficiency and utility of this work. The substrates we are targeting are representative of
common structural components found in pharmaceuticals, natural products, agrochemicals, and sensory
materials. The availability of these new technologies will allow others to prepare a variety of highly-
functionalized and structurally diverse compounds, many of which have previously been inaccessible,
which will have a great impact in a range of areas that are directly important to human health.
Public Health Relevance Statement
Project Narrative:
The chemistry we are proposing will allow improved access to molecules of importance in biomedical
research in both academia and industry. The ligands, catalysts, techniques, and strategies that we have
developed for carbon-heteroatom and carbon-carbon bond formation are regularly used by those in
discovery and process groups in the pharmaceutical industry for the preparation of new biologically
relevant compounds and are also widely used in academia. The methods we are devising enable
chemists to rapidly and reliably prepare molecular analogs that manifest increased potency and reduced
side effects as compared to the initial lead compounds, allows for faster, more economical, and efficient
drug discovery and development, thus leading to an improvement in human health.
No Sub Projects information available for 2R35GM122483-06
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 2R35GM122483-06
Patents
No Patents information available for 2R35GM122483-06
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 2R35GM122483-06
Clinical Studies
No Clinical Studies information available for 2R35GM122483-06
News and More
Related News Releases
No news release information available for 2R35GM122483-06
History
No Historical information available for 2R35GM122483-06
Similar Projects
No Similar Projects information available for 2R35GM122483-06